Literature DB >> 11827646

Central Nervous System Germ Cell Tumors.

Regina Jakacki1.   

Abstract

Germ cells tumors most commonly affect children and adolescents, and occasionally arise in the central nervous system. Except for mature teratomas, they are all malignant. Pure germinomas are exquisitely sensitive to treatment and are highly curable with craniospinal radiation therapy. Surgery plays no role other than to establish the histologic diagnosis. Diagnostic confirmation includes normal levels of serum and cerebrospinal fluid alpha-fetoprotein and at most only minor elevations in beta human chorionic gonadotrophin (beta-hCG). Although it has become quite common to use chemotherapy to reduce the dose and field of radiation in the treatment of germinomas, longer follow-up in these patients is revealing a significant number of subarachnoid and ventricular recurrences. A recent follow-up study in patients treated for intracranial germinomas showed no significant difference in the psychosocial functioning of those treated with chemotherapy and radiation compared with those treated with chemotherapy alone, which raises further questions about the rationale for modifying a proven successful treatment. Malignant non-germinomatous germ cell tumors are much more resistant to treatment and difficult to cure. Surgical resection appears to have prognostic significance, although the predilection for midline structures makes complete resection difficult if not impossible at times. The best results have been obtained with platinum-based chemotherapy and full-dose craniospinal radiation therapy. Pure teratomas are not typically responsive to chemotherapy or radiation therapy and surgery is the only proven treatment modality.

Entities:  

Year:  2002        PMID: 11827646     DOI: 10.1007/s11940-002-0022-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  17 in total

1.  Management of primary intracranial germinomas: diagnostic surgery or radical resection?

Authors:  Y Sawamura; N de Tribolet; N Ishii; H Abe
Journal:  J Neurosurg       Date:  1997-08       Impact factor: 5.115

2.  Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy.

Authors:  P L Robertson; R C DaRosso; J C Allen
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

3.  Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue.

Authors:  T Tada; T Takizawa; F Nakazato; S Kobayashi; K Koike; M Oguchi; E Ishii; Y Amano
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

4.  Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89.

Authors:  M Bamberg; R D Kortmann; G Calaminus; G Becker; C Meisner; D Harms; U Göbel
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

5.  Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma.

Authors:  Y Sawamura; H Shirato; J Ikeda; M Tada; N Ishii; T Kato; H Abe; K Fujieda
Journal:  J Neurosurg       Date:  1998-01       Impact factor: 5.115

6.  A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system.

Authors:  J C Allen; R C DaRosso; B Donahue; A Nirenberg
Journal:  Cancer       Date:  1994-08-01       Impact factor: 6.860

7.  Intracranial germ cell tumors: a comprehensive update of the European data.

Authors:  G Calaminus; M Bamberg; M C Baranzelli; Y Benoit; L C di Montezemolo; F Fossati-Bellani; H Jürgens; H J Kühl; H G Lenard; M L Curto
Journal:  Neuropediatrics       Date:  1994-02       Impact factor: 1.947

8.  Treatment results of intracranial germinoma as a function of the irradiated volume.

Authors:  Y Shibamoto; M Abe; J Yamashita; M Takahashi; M Hiraoka; K Ono; K Tsutsui
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-08       Impact factor: 7.038

Review 9.  Intracranial germ-cell tumors: natural history and pathogenesis.

Authors:  M T Jennings; R Gelman; F Hochberg
Journal:  J Neurosurg       Date:  1985-08       Impact factor: 5.115

10.  Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique.

Authors:  E Bouffet; M C Baranzelli; C Patte; M Portas; C Edan; P Chastagner; F Mechinaud-Lacroix; C Kalifa
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  4 in total

Review 1.  Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors.

Authors:  Xiang Huang; Rong Zhang; Ying Mao; Liang-Fu Zhou; Chao Zhang
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

2.  Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study.

Authors:  Antonio Silvani; Marica Eoli; Andrea Salmaggi; Elena Lamperti; Laura Fariselli; Ida Milanesi; Giovanni Broggi; Carlo Lazzaro Solero; Sergio Giombini; Amerigo Boiardi
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

3.  Intracranial germinoma: clinical and MRI findings in 56 patients.

Authors:  Yajie Wang; Liping Zou; Baoqin Gao
Journal:  Childs Nerv Syst       Date:  2010-07-28       Impact factor: 1.475

Review 4.  Suprasellar Mature Cystic Teratoma Mimicking Rathke's Cleft Cyst: A Case Report and Systematic Review of the Literature.

Authors:  Shenzhong Jiang; Zhaojian Wang; Yan You; Renzhi Wang; Xinjie Bao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-30       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.